Drug Shortage Report for TOBRAMYCIN INJECTION
| Report ID | 164261 |
| Drug Identification Number | 02230640 |
| Brand name | TOBRAMYCIN INJECTION |
| Common or Proper name | TOBRAMYCIN INJECTION |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | TOBRAMYCIN |
| Strength(s) | 40MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 2mL |
| ATC code | J01GB |
| ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2022-07-01 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2022-10-03 |
| Company comments | Effective July 1, 2022 our Tobramycin Injection 40 mg/mL MD Vial 2 mL will be placed on allocation. Contract customers will be allocated 100% of historical monthly demand. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2022-10-03 | French | Compare |
| v8 | 2022-10-03 | English | Compare |
| v7 | 2022-10-02 | French | Compare |
| v6 | 2022-10-02 | English | Compare |
| v5 | 2022-08-04 | French | Compare |
| v4 | 2022-08-04 | English | Compare |
| v3 | 2022-07-07 | French | Compare |
| v2 | 2022-07-07 | French | Compare |
| v1 | 2022-07-07 | English | Compare |
Showing 1 to 9 of 9